AstraZeneca Vaxzevria COVID-19 Vaccine from Germany
Vaxzevria uses chimpanzee adenovirus vector expressing SARS-CoV-2 spike for immunity. Retail multi-dose vials qualify under HTS 3002.15.00 immunological products.
Duty Rate — Germany → United States
15%
Rate breakdown
9903.04.6215%Patented pharmaceutical articles that are the product of Japan, of a European Union member country, of South Korea, of Switzerland, or of Liechtenstein as provided for in subdivisions (c) and (f) of U.S. note 40 to this subchapter
9903.05.860%Articles provided for in subdivision (b) of U.S. note 52 to this subchapter
Import Tips
• Shake well before dose; silicone-free syringes required
• TTS (thrombosis) risk labeling mandatory
• Live vector elements may trigger 3002.30 review